UBS raised its price target on Halliburton to $55 from $50 following meetings with management. The firm calls Halliburton the "go-to" name in the sector as they believe there is a real possibility that oil prices will surprise to the upside in 2017. UBS raised its North American margins estimates, while lowering margins for Latin America, and sees the potential for an increase to estimates based on the pace of the U.S. land recovery and/or oil price upside. UBS reiterated its Buy rating on Halliburton shares.

Unusual total active option classes on open include: ImmunityBio (IBRX), Halliburton (HAL), Redfin (RDFN), Nokia (NOK), Matterport (MTTR), General Motors (GM), UPS (UPS), Philip Morris (PM), PepsiCo (PEP), and General Electric (GE).

Reports Q1 revenue $5.8B, consensus $5.67B. "Halliburton delivered solid first quarter results that again demonstrated the power of our strategy and the strength of our execution. Activity in North America recovered from fourth-quarter lows, and our international business delivered its 11th consecutive quarter of year-on-year growth," commented Jeff Miller, Chairman, President and CEO. "Our customers' multi-year activity plans across markets and asset types confirms my confidence in the strength and duration of this upcycle. Halliburton demonstrated its commitment to shareholder returns in the first quarter and repurchased $250 million of common stock - a solid start to the year and a good benchmark for our expectations going forward," concluded Miller.